No Data
Jiangsu Chinagreen Biological Technology Group: 2025 First Quarter Report
Jiangsu Chinagreen Biological Technology Group: Summary of the 2024 Annual Report
Jiangsu Chinagreen Biological Technology Group: 2024 Annual Report
Hualv Biological (300970.SZ): In the first quarter, the Net income was 1.5447 million yuan, a year-on-year decrease of 11.20%.
On April 23, Gelonghui reported that Hualu Biological (300970.SZ) released its Q1 2025 report, achieving revenue of 0.271 billion yuan, a year-on-year increase of 5.33%; net income attributable to shareholders of the listed company was 1.5447 million yuan, a year-on-year decrease of 11.20%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.12898 million yuan, a year-on-year increase of 38.07%; EPS was 0.01 yuan.
Brokerage morning meeting highlights: Countermeasures against tariffs boost Shenzhen Agricultural Products Group prices, the planting chain directly benefits.
At today's Brokerage morning meeting, CITIC SEC believes that countermeasures against tariffs boost the prices of Shenzhen Agricultural Products Group, which directly benefits the planting chain; HAITONG SEC proposed a bullish view on the relative yields of the Banks Sector in April; Galaxy Securities stated that it focuses on Gold and countermeasures against rare earths.
Hua Green Biological (300970.SZ) announced a pre-loss, expecting a net loss of 38 million to -56 million yuan for the year 2024.
Hualu Biological (300970.SZ) announced that the company expects the net income attributable to Shareholders of the listed company for the year 2024 to be...